Skip to main content
SpringerLink
Log in

Expression of Syk in non-small cell lung cancer and its relationship with clinicopathological parameters

  • Research Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

This study aims to research the expression of spleen tyrosine kinase (Syk) in non-small cell lung cancer (NSCLC) and the relationship between Syk and clinicopathologic factors and p53. Immunohistochemistry was applied to detect the expression of Syk and p53 protein in 39 cases of NSCLC (23 cases of lung squamous cell cancer, 16 cases of lung adenocarcinoma) and tumor-surrounding normal lung tissues. The positive rate of Syk was 46.15% (18/39) and 100% (39/39) in NSCLC and tumorsurrounding normal lung tissues, respectively. The expression level of Syk in NSCLC was significantly lower than that in tumor-surrounding normal lung tissues (P = 0.000). The Syk expression was positively correlated with the p53 expression in NSCLC specimens (P = 0.025). There was no significant association between Syk expression and lymph node metastasis, differentiation degree, tumor size and tumor node metastasis (TNM). The present study demonstrated that Syk was aberrantly expressed in the NSCLC and might have a significant impact on tumor growth and progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ding Y B, Wu Z Y, Wang S, Fan P, Zha X M, Zheng W, Liu X A. Expression of tyrosine kinase Syk in breast cancer and their clinical significance. Nanjing Yike Daxue Xuebao, 2004,18(3): 128–132 (in Chinese)

    Google Scholar 

  2. Zhang K L, Wang S F, Wen M, Zheng B M, Di W, Li Y Y. The expression and signi.cance of Syk and C-erB-2, PCNA in patients with breast cancer. Zhongguo Aizheng Zazhi, 2006, 15(2): 131–133 (in Chinese)

    CAS  Google Scholar 

  3. Nakashima H, Natusugoe S, Ishigami S, Okumura H, Matsumoto M, Hokita S, Aikou T. Clinical signi.cance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer. Cancer Lett, 2006, 236(1): 89–94

    Article  PubMed  CAS  Google Scholar 

  4. Qin B S, Li G C. Significance of expression of spleen tyrosine kinase (Syk) in gastric carcinoma. Zhongguo Wuzhenxue Zazhi, 2006, 6: 411–412 (in Chinese)

    Google Scholar 

  5. Xia J G, Ding Y B, Chen G Y. Expression of tyrosine kinase Syk and its clinical significance in gastric carcinoma. Shijie Huaren Xiaohua Zazhi, 2004, 12(4): 767–769 (in Chinese)

    CAS  Google Scholar 

  6. Chen M X, Ding Y B, Jiang K R, Mao Y. Expression of tyrosine kinase Syk and its clinical significance in pancreatic cancer. Nanjing Daxue Xuebao, 2003, 23(5): 492–493 (in Chinese)

    CAS  Google Scholar 

  7. Sada K, Takano T, Yanaji S, Yamamura H. Structure and function of Syk protein-tyrosine kinase. J Biochem, 2001, 130(2): 177–186

    PubMed  CAS  Google Scholar 

  8. Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K, Kawakami Y. Prognostic significance of p53 and ras p21 expression in non-small cell lung cancer. Cancer, 1995,76(12): 2457–2463

    Article  PubMed  CAS  Google Scholar 

  9. Okamura S, Ng C C, Koyama K, Takei Y, Arakawa H, Monden M, Nakamura Y. Identification of seven genes regulated by wile-type p53 in a colon cancer cell line carrying a well-controlled wile-type p53 expression system. Oncol Res, 1999,11(6): 281–285

    PubMed  CAS  Google Scholar 

  10. Ding Y B, Wu Z Y, Wang S, Fan P, Zha X M, Zheng W, Liu X A. Expression of tyrosine kinase Syk in breast cancer and their clinical significance. Zhonghua Wai Ke Za Zhi, 2004, 42(3): 137–139 (in Chinese)

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Key Laboratory of Pulmonary Diseases of Ministry of Health of China, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430300, China

    Fen Lan, Shengdao Xiong, Weining Xiong, Guopeng Xu & Xiaoxia Lu

Authors
  1. Fen Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shengdao Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weining Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guopeng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaoxia Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shengdao Xiong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lan, F., Xiong, S., Xiong, W. et al. Expression of Syk in non-small cell lung cancer and its relationship with clinicopathological parameters. Front. Med. China 3, 41–44 (2009). https://doi.org/10.1007/s11684-009-0009-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-009-0009-6

Keywords

Search

Navigation